Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Khim ; 58(4): 385-99, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23413683

RESUMO

In-depth scholar literature analysis of Alzheimer's disease neurodegenerative features of amyloid beta protein neurochemistry modification and excessive phosphorylation of tau protein (and associated neuronal cytoskeleton rearrangements) are secondary phenomena. At early disease stage these neurobiochemical mechanisms are reversible and serve to heal an impairment of biophysical properties of neuronal membranes, neurotransmission, basic neuronal function and neuroplasticity, while preserving anatomical and functional brain fields. Abeta and tau could well serve to biochemically restore physico-chemical properties of neual membranes due to a role these proteins play in lipid metabolism. Under such scenario therapeutic block of aggregation and plaque formation of Abeta and inhibition of tau phosphorylation, as well as pharmaceutical modification of other secondary neurodegenerative features (such as a cascade of oxidative stress reactions) are unable to provide an effective cure of Alzheimer's disease and related pathologies of the Central and peripheral nervous systems, because they are not arraying primary pathagenetic cause. We review the role of Abeta in compensatory mechanisms of neuroplasticity restoration under normal physiological condition and Alzheimer's disease.


Assuntos
Doença de Alzheimer/metabolismo , Doença de Alzheimer/fisiopatologia , Precursor de Proteína beta-Amiloide/metabolismo , Amiloide/metabolismo , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Plasticidade Neuronal , Doença de Alzheimer/patologia , Animais , Encéfalo/patologia , Humanos , Neurônios/metabolismo , Neurônios/patologia , Estresse Oxidativo , Proteínas tau/metabolismo
2.
Biomed Khim ; 58(4): 438-45, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23413688

RESUMO

Oxidizing stress in rats with experimental diabetes mellitis is accompanied by endothelial dysfunction develops. Its biochemical markers are the increase of concentration of blood MDA, the impairments of cell antioxidant depence and a decrease in concentration of total metabolites of NO and expression of endothelial NO-synthetase (e-NOS). Biochemical changes are considered with histopathomorphologic impairments of aortic endothelium. Treatment with afobazole suppressed free-radical oxidation, increased activity of SOD and concentration of total metabolites of NO and a level of eNOS expression and also restored of a histologic pattern of aortic endothelium due to activation of nucleocytoplasmic regenerative processes.


Assuntos
Benzimidazóis/farmacologia , Diabetes Mellitus Experimental/sangue , Endotélio Vascular/metabolismo , Radicais Livres/sangue , Malondialdeído/sangue , Morfolinas/farmacologia , Óxido Nítrico/sangue , Animais , Aorta/metabolismo , Aorta/patologia , Biomarcadores/sangue , Diabetes Mellitus Experimental/patologia , Endotélio Vascular/patologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Masculino , Óxido Nítrico Sintase Tipo III/biossíntese , Oxirredução/efeitos dos fármacos , Ratos
3.
Vestn Ross Akad Med Nauk ; (7): 3-9, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12187538

RESUMO

This is the first assessment of the pathogenetic values of some environmental factors in the occurrence and progression of cerebral beta-amyloidosis (Alzheimer's disease, senile dementia) in long-livers of different climatic areas of the Republic of North Ossetia-Alania. New isoenzyme serum assays for determining creatine kinase BB-isoenzyme and the transaminase activity in the spinal fluid are proposed, which may be used as potential markers in the biochemical diagnosis of Alzheimer's disease. They can both provide valuable information on the severity of morphological lesions of cerebral cells in Alzheimer's disease and serve as the basis for the differential diagnosis of different forms of dementia wherein dystrophic changes in CNS cells are absent or slightly pronounced.


Assuntos
Doença de Alzheimer/enzimologia , Creatina Quinase/líquido cefalorraquidiano , Isoenzimas/líquido cefalorraquidiano , Transaminases/líquido cefalorraquidiano , Idoso , Idoso de 80 Anos ou mais , Altitude , Doença de Alzheimer/líquido cefalorraquidiano , Doença de Alzheimer/patologia , Biomarcadores/líquido cefalorraquidiano , Encéfalo/enzimologia , Encéfalo/patologia , Creatina Quinase Forma BB , Feminino , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA